MAI Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.58M | Buy |
22,613
+2,448
| +12% | +$171K | 0.01% | 534 |
|
|
2025
Q1 | $1.48M | Sell |
20,165
-1,040
| -5% | -$76.4K | 0.01% | 528 |
|
|
2024
Q4 | $1.39M | Buy |
21,205
+7,649
| +56% | +$501K | 0.01% | 540 |
|
|
2024
Q3 | $1.06M | Sell |
13,556
-5,525
| -29% | -$430K | 0.01% | 528 |
|
|
2024
Q2 | $1.49M | Buy |
19,081
+2,176
| +13% | +$170K | 0.01% | 471 |
|
|
2024
Q1 | $1.15M | Sell |
16,905
-296
| -2% | -$20.1K | 0.01% | 518 |
|
|
2023
Q4 | $1.16M | Buy |
17,201
+224
| +1% | +$15.1K | 0.02% | 424 |
|
|
2023
Q3 | $1.15M | Sell |
16,977
-264
| -2% | -$17.9K | 0.02% | 395 |
|
|
2023
Q2 | $1.23M | Sell |
17,241
-5,414
| -24% | -$387K | 0.02% | 386 |
|
|
2023
Q1 | $1.57M | Sell |
22,655
-1,185
| -5% | -$82.3K | 0.02% | 337 |
|
|
2022
Q4 | $1.62M | Buy |
23,840
+8,450
| +55% | +$573K | 0.03% | 319 |
|
|
2022
Q3 | $844K | Buy |
15,390
+8,767
| +132% | +$481K | 0.02% | 404 |
|
|
2022
Q2 | $438K | Sell |
6,623
-403
| -6% | -$26.7K | 0.01% | 555 |
|
|
2022
Q1 | $466K | Buy |
7,026
+1,237
| +21% | +$82K | 0.01% | 559 |
|
|
2021
Q4 | $337K | Sell |
5,789
-878
| -13% | -$51.1K | 0.01% | 645 |
|
|
2021
Q3 | $400K | Buy |
6,667
+2,191
| +49% | +$131K | 0.01% | 542 |
|
|
2021
Q2 | $268K | Buy |
+4,476
| New | +$268K | 0.01% | 611 |
|